OrthoPediatrics Corp. announced Monday it has negotiated a $37 million equity investment to support new product introductions, an expected increase in employment and other initiatives.
The investment comes from the Warsaw company’s largest shareholder and financial partner, Squadron Capital LLC. The investment will be used in part to support the pediatric orthopedic device maker’s sales growth in 28 countries and enable it to reduce and restructure the debt on its balance sheet, according to the announcement, which also says this is expected to be the last private capital raise needed by the company.
OrthoPediatrics introduced two major new products at the 2014 meeting of the Pediatric Orthopedic Society of North America Wednesday through Saturday. The Response™ Spine System and the OrthoPediatrics Anterior Cruciate Ligament Reconstruction System represent the company’s expansion from the pediatric trauma and deformity correction market into the scoliosis and sports medicine markets.
OrthoPediatrics now offers the broadest line of surgical systems used in the three segments of the pediatric orthopedic industry, the announcement states.
Mark C. Throdahl, OrthoPediatrics president and CEO, said in the release, “In an environment where major orthopedic companies are consolidating and cutting headcount, OrthoPediatrics is expanding employment and investing in important new surgical systems. We are successfully implementing our strategy of building an enduring orthopedic company and surrounding pediatric orthopedists with all the surgical systems they need. We are committed to improving the lives of children with orthopedic conditions through the development of new products and supporting pediatric surgical associations in the United States and abroad.”
Founded in 2007 by orthopedic industry veteran Nick Deeter, OrthoPediatrics has become the only end-to-end provider to pediatric orthopedic surgeons, according to the release, with 16 surgical systems and distributors in 28 countries. The company has increased its headcount from 48 to an anticipated 87 by year’s end.
Squadron Capital, founded in 2008, is an investment vehicle funded by a Chicago-based trust and led from its headquarters near Hartford, Conn. Squadron Capital has an investment focus on developers and manufacturers of orthopedic medical devices, implants and surgical instrumentation.